LivaNova PLC (NASDAQ:LIVN) Receives $69.17 Consensus Target Price from Analysts

LivaNova PLC (NASDAQ:LIVN - Get Free Report) has been assigned an average rating of "Buy" from the seven analysts that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation, five have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $69.17.

Several analysts have issued reports on the company. Mizuho lowered their target price on LivaNova from $80.00 to $70.00 and set an "outperform" rating on the stock in a research note on Thursday, October 31st. StockNews.com cut LivaNova from a "strong-buy" rating to a "buy" rating in a research note on Saturday, November 16th. Baird R W raised shares of LivaNova from a "hold" rating to a "strong-buy" rating in a report on Tuesday, September 17th. The Goldman Sachs Group began coverage on shares of LivaNova in a research note on Friday, October 4th. They issued a "buy" rating and a $65.00 target price for the company. Finally, Needham & Company LLC restated a "buy" rating and set a $75.00 price target on shares of LivaNova in a research note on Monday, November 25th.

Institutional Trading of LivaNova

Hedge funds and other institutional investors have recently bought and sold shares of the company. Sanctuary Advisors LLC purchased a new position in LivaNova during the third quarter worth about $219,000. Geode Capital Management LLC boosted its position in shares of LivaNova by 0.6% during the 3rd quarter. Geode Capital Management LLC now owns 1,344,949 shares of the company's stock valued at $70,676,000 after acquiring an additional 8,331 shares during the last quarter. XTX Topco Ltd purchased a new position in shares of LivaNova during the third quarter worth about $550,000. Point72 DIFC Ltd increased its position in shares of LivaNova by 75,799.6% in the third quarter. Point72 DIFC Ltd now owns 181,400 shares of the company's stock worth $9,531,000 after purchasing an additional 181,161 shares during the last quarter. Finally, Point72 Asset Management L.P. raised its stake in LivaNova by 62.7% in the third quarter. Point72 Asset Management L.P. now owns 2,092,010 shares of the company's stock valued at $109,914,000 after purchasing an additional 806,374 shares in the last quarter. Institutional investors own 97.64% of the company's stock.

LivaNova Stock Performance

Shares of LivaNova stock traded down $0.67 on Tuesday, reaching $51.62. 410,662 shares of the company traded hands, compared to its average volume of 609,249. The company has a 50 day moving average of $52.29 and a 200 day moving average of $51.95. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.37 and a quick ratio of 2.87. LivaNova has a 52 week low of $42.75 and a 52 week high of $64.47. The firm has a market capitalization of $2.80 billion, a PE ratio of 122.90 and a beta of 0.98.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.